Is captopril safe for use in a pregnant or lactating woman with hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Captopril Safety in Pregnancy and Lactation

Captopril is absolutely contraindicated during pregnancy but is safe during lactation.

Pregnancy: Absolute Contraindication

ACE inhibitors including captopril must never be used during pregnancy due to severe fetotoxicity. 1, 2, 1 The evidence is unequivocal across all major guidelines:

  • Captopril causes renal dysgenesis, oligohydramnios from fetal oliguria, neonatal anuric renal failure, intrauterine growth retardation, pulmonary hypoplasia, and fetal death, especially in the second and third trimesters. 1, 2, 1

  • While the teratogenic effects are most severe in the second and third trimesters, ACE inhibitors should be avoided throughout all trimesters of pregnancy. 3, 4 First trimester exposure remains controversial, with some data suggesting adverse effects may relate to maternal hypoperfusion rather than direct teratogenicity, but the risk-benefit analysis clearly favors complete avoidance. 4, 5

  • The frequency of serious perinatal complications is high enough to warrant extreme reluctance in prescribing ACE inhibitors during pregnancy. 6

Safe Alternatives for Pregnant Hypertensive Women

For pregnant women requiring antihypertensive therapy, the following medications are recommended as first-line agents:

  • Extended-release nifedipine is the preferred first-line agent with the strongest safety data and once-daily dosing advantage. 7, 8

  • Labetalol is equally effective with comparable safety profile, though contraindicated in reactive airway disease. 7, 8

  • Methyldopa has the longest safety record with documented follow-up of children up to 7.5 years, though it should be switched postpartum due to depression risk. 9, 7

Lactation: Safe to Use

Captopril is explicitly listed as safe during lactation. 1, 2, 1 The 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guidelines specifically state that "benazepril, captopril, and enalapril are safe during lactation." 1, 2, 1

Important Caveats for Lactation Use

  • ACE inhibitors can be used in lactating mothers unless the neonate is premature or has renal failure. 9

  • While captopril is safe, enalapril is specifically listed as the most widely used ACE inhibitor for lactation due to its safety and favorable pharmacokinetics, particularly suitable for peripartum cardiomyopathy treatment. 9

Critical Clinical Pitfalls to Avoid

  • Never continue ACE inhibitors in women of childbearing age without confirmed contraception, as 50% of pregnancies are unplanned and early exposure causes fetal harm. 10

  • Transition women planning pregnancy to pregnancy-safe antihypertensives (nifedipine, labetalol, or methyldopa) before conception attempts begin. 7, 10

  • Do not assume first trimester exposure is safe - while the mechanism may differ from later trimester effects, the prudent approach is complete avoidance throughout pregnancy. 6, 4

  • Remember to switch from captopril to pregnancy-safe alternatives immediately upon pregnancy confirmation if inadvertent exposure occurs, though the damage from second/third trimester exposure is most severe. 1, 3

References

Research

Angiotensin converting enzyme inhibitors use in the first trimester of pregnancy.

The International journal of risk & safety in medicine, 1997

Guideline

Antihypertensive Medication for Women of Childbearing Age Planning Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nifedipine vs Amlodipine Safety in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Hypertension in Individuals Undergoing Fertility Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Why is amlodipine avoided in pregnant patients?
How should a patient on amlodipine (calcium channel blocker) 10mg daily and metoprolol (beta-blocker) 50mg daily be switched to a pregnancy-friendly antihypertensive regimen?
Can a woman who is 9 weeks pregnant safely switch from losartan (an angiotensin II receptor blocker) to another antihypertensive medication?
Which antihypertensive agents are safe for use in a breastfeeding woman?
What is the preferred β‑blocker for treating hypertension or tachyarrhythmia in pregnant patients, and what are the recommended dosing regimen and safety precautions?
Should enoxaparin (Lovenox) be held before an endoscopic retrograde cholangiopancreatography (ERCP), and what is the appropriate discontinuation interval based on therapeutic versus prophylactic dosing and renal function?
How can I explain polyclonal gammopathy to my patient?
How should I manage a patient with elevated thyroid‑stimulating hormone (TSH), normal free triiodothyronine (FT3) and free thyroxine (FT4), who has symptoms of hypothyroidism?
For a patient with oropharyngeal carcinoma, is prescribing 50.4 Gy in 28 fractions (1.8 Gy per fraction) to intermediate‑risk lymph nodes using intensity‑modulated radiation therapy (IMRT) appropriate, or should the elective dose be increased to 54 Gy or a boost added, and is concurrent cisplatin chemotherapy indicated?
Why is examination of at least twelve regional lymph nodes required in colorectal cancer resection?
What is lipid variability and how should it be managed to achieve stable, low LDL‑cholesterol levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.